NCT02292719View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 19, 2014

Primary Completion Date

July 14, 2017

Study Completion Date

July 14, 2017

Conditions
Chronic Hepatitis C Virus Infection
Interventions
DRUG

OBV/PTV/r

Tablet

DRUG

Sofosbuvir

Tablet

DRUG

Ribavirin (RBV)

Tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT02292719 - A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter